Miami Cancer Institute, part of Baptist Health South Florida now offers pancreatic cancer patients the possibility of living longer. Recently Michael Chuong, MD, medical director of Radiation Oncology at the Institute, presented Miami Cancer Institute’s long-term results of MR-guided stereotactic ablative radiation therapy (SABR) at the European Society for Radiotherapy and Oncology (ESTRO) 2021 conference in Madrid on August 29. Dr. Chuong reports that MR-guided SABR delivers nearly twice the radiation dose that is safe to deliver to a patient over five days with conventional radiation therapy machines. Consequently the hypothesis for an ongoing clinical trial: that this approach may result in better outcomes potentially keeping a pancreatic cancer patient alive for years. An outpatient procedure, MR-guided SABR is apparently painless and non-invasive that apparently doesn’t generate significant side effects.
TrialSite provides a breakdown of this recent update from Miami Cancer Institute.
How dangerous is pancreatic cancer?
Extremely dangerous. The most deadly cancer in the United States, over 60,000 people in the country are diagnosed with the disease annual...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).